DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Cohance Lifesciences Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·23 Jul 2026, 7:57 am

Cohance Lifesciences

Cohance Lifesciences has informed exchanges about a scheduled meeting with analysts and institutional investors. This announcement signals that the company is preparing to share detailed insights into its business performance, future strategy, and operational outlook with the investment community.

For investors, such updates are a key opportunity to understand management's vision beyond standard financial reports. It helps clarify the company's growth trajectory and address any market uncertainties directly from the source.

Investors should watch for the specific dates of the meeting and the key themes management plans to discuss. This information will be crucial for assessing the stock's short-term momentum and the company's long-term potential.